• Accueil
• the bio
• Iambic Therapeutics Charting new paths to superior medicines

Iambic Therapeutics Charting new paths to superior medicines

4.6 (746) · € 17.50 · En Stock

Phil Mcgraw

News & Media Iambic Therapeutics

Platform Iambic Therapeutics

Platform Iambic Therapeutics

Iambic Therapeutics Marks a Key Milestone in Advancing Cancer Treatment: IND Submission for IAM1363, a Selective, Brain-Penetrant HER2 Inhibitor

PDF) Language acquisition and speech rhythm patterns: an auditory neuroscience perspective

Entos (Now Iambic) in Collaboration with Caltech and NVIDIA: Advances in geometric deep learning for computational chemistry in Proceedings of the National Academy of Science USA

Iambic Therapeutics

Privacy Iambic Therapeutics

News & Media Iambic Therapeutics